Peripheral Artery Occlusive Disease Among Patients With Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors: A Cross-Sectional Case-Control Study

Peripheral Artery Occlusive Disease Among Patients With Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors: A Cross-Sectional Case-Control Study

Background: There were some reports of peripheral artery occlusive disease (PAOD) associated with nilotinib usage in chronic myeloid leukemia (CML). These complications in other tyrosine kinase inhibitors are revealed as unknown. Materials and methods: We determined the prevalence of PAOD in patient...

Full description

Bibliographic Details
Main Authors: Thanawat Rattanathammethee, Adisak Tantiworawit, Ekarat Rattarittamrong, Chatree Chai-Adisaksopha, Sasinee Hantrakool, Arintaya Phrommintikul, Wanwarang Wongcharoen, Siriluck Gunaparn, Lalita Norasetthada
Format: Article
Language:English
Published: SAGE Publishing 2017-12-01
Series:Clinical Medicine Insights: Cardiology
Online Access:https://doi.org/10.1177/1179546817747258

Internet

https://doi.org/10.1177/1179546817747258

Similar Items